Augurex Overview
- Founded
-
2006
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Later Stage VC
- Investors
-
3
Augurex General Information
Description
Developer of bio-marker blood tests designed to transform patient clinical management for improved disease outcomes. The company's bio-marker blood tests are based on point-of-care proprietary blood testing that connects with disease-specific applications and electronic health records, enabling doctors to optimize patient management by personalizing clinical decision-making.
Contact Information
Website
www.augurex.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Outcome Management (Healthcare)
Primary Office
- 887 Great Northern Way
- Suite 220
- Vancouver, British Columbia V5T 4T5
- Canada
+1 (604) 000-0000
Augurex Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 25-Jan-2017 | 00000 | Completed | Generating Revenue | ||
| 4. Angel (individual) | 01-Feb-2011 | 000.00 | 00000 | Completed | Startup | |
| 3. Angel (individual) | 01-May-2009 | 000.00 | 000.00 | Completed | Startup | |
| 2. Angel (individual) | 01-Nov-2007 | $52.8K | $52.8K | Completed | Startup | |
| 1. Grant | 01-Jan-2007 | $52.8K | Completed | Startup |
Augurex Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of bio-marker blood tests designed to transform patient clinical management for improved disease outcomes. The
Diagnostic Equipment
Vancouver, Canada
11
As of 2022
00000
0000000000 0
00000
000000
giat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deser
00000 0000000000 0000000000 0000000
Miami, FL
000
As of 0000
00000
000000000
00000
000000
in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat n
0000000000000
Boston, MA
000
As of 0000
00000
0000
0000-00-00
00000000000
00000
Add Comparison
Augurex Competitors (10)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BioTissue (Healthcare Technology Systems) | Venture Capital-Backed | Miami, FL | 000 | 00000 | 000000000 | 00000 |
| 0000000 | Venture Capital-Backed | Boston, MA | 000 | 00000 | 00000000000 | 00000 |
| 0000 0000 | Venture Capital-Backed | Burlingame, CA | 00 | 000.00 | 00000000000 | 000.00 |
| 0000000 0000000000 | Formerly VC-backed | Redwood City, CA | 000 | 00000 | 00000000000 | 00000 |
| 00000000 | Accelerator/Incubator Backed | Toulouse, France | 00 | 0000000000 |
Augurex Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Norma Biln | Co-Founder, Chief Executive Officer & Director |
Augurex Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| David Demers | Self | Board Member | 000 0000 |
| Doug Buchanan | Self | Board Member | 000 0000 |
| Natalie Dakers | Augurex | Chairman | 000 0000 |
| Paul Terry Ph.D | Self | Board Member | 000 0000 |
| Tim Chan | Self | Board Member | 000 0000 |
Augurex Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Augurex Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Genome British Columbia | Not-For-Profit Venture Capital | Minority | 000 0000 | 000000 0 | |
| WUTIF Capital | Angel Group | Minority | 000 0000 | 000000 0 | |
| New Ventures BC | Accelerator/Incubator | 000 0000 | 000000 0 |